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Background
The human designer cell line AGE1.HN
® represents a
promising production system for biopharmaceuticals,
particularly for those needing human-type post-transla-
tional modifications [1,2]. For further rational improve-
ment of the cell line and the cultivation process a
detailed understanding of the metabolism and metabolic
changes during glycoprotein production is desirable.
Metabolism and metabolic burden upon production of
a1-antitrypsin (A1AT) were analyzed by comparing par-
ental cells and a derived clone, AGE1.HN.AAT. The
questions addressed were (i), which changes occur in
cell growth and metabolism upon A1AT production and
(ii), what are specific cellular properties distinguishing
the producer clone AGE1.HN.AAT from the parental
cell population.
Materials and methods
Cultivation and analysis
Cultivations of the human neuronal cell line AGE1.HN
®
(ProBioGen AG, Berlin, Germany) were carried out in
shake flasks (Corning, NY, USA). Extracellular metabo-
lites were quantified using different HPLC methods
[3,4]. A1AT was quantified using an activity assay. Iden-
tification of extracellular proteins was done using
MALDI-ToF/ToF MS (Applied Biosystems). Biomass
components were quantified using classical biochemical
methods.
Model for A1AT production
Model for A1AT production was set up using the Kyoto
Encyclopedia of Genes and Genomes (http://www.kegg.
com) pathway database for Homo sapiens.
Metabolic flux analysis
Fluxes were estimated using standard methods [1,5] by
incorporating extracellular and anabolic rates using
Matlab R2007b (The Mathworks, Natick, MA, USA).
Results
Cell growth was similar in the first 5 days. After 5 days
AGE1.HN.AAT cells were growing less than the paren-
tal cell line and the viability dropped faster. After 2 days
dry weight was slightly higher in the parental cell line.
A1AT production was low in the first 2 days and then
increasing up to a final concentration of ~0.4 g/l in the
end of the cultivation. The total cell mass was increasing
similarly in the first 4 days. After 4 days AGE1.HN.AAT
cell mass remained constant whereas the extracellular
protein concentration was increasing. This was different
in the AGE1.HN parental cells where the cell mass was
still increasing after 4 days and the increase in total
extracellular protein mass was less. Intracellular protein
concentration was decreasing in AGE1.HN.AAT after 4
days. Specific cellular proteins might be degraded upon
nutrient deprivation to maintain the production of the
recombinant glycoprotein A1AT. This was clearly differ-
ent in the parental cell line. Fractions of the biomass
constituents RNA, lipid and phosphatidylcholine were
increased in AGE1.HN.AAT. The total mass of the ana-
lyzed components in the end of the cultivation was
similar in the cultivations of both cell lines being around
2.5 g/l. The final A1AT concentration which was 0.4 g/l
was ~30 % of the total protein in the culture.
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were observed. Glycine and glutamate production was
higher in AGE1.HN.AAT whereas uptake of arginine
and aspartate as well as alanine production were lower.
Glutamine was consumed in the cultivations of both cell
lines at ~4 days which resulted also in reduced growth.
Especially the increase in glycine and glutamate produc-
tion points to differences in C1 metabolism and cellular
nucleotide demand.
The differences that can be seen in the metabolism
upon production of the glycoprotein were explained
by using an appropriate model of the anabolic
demand needed to produce active A1AT. The whole
cellular production process of a glycoprotein includes
its expression (transcription), synthesis of the amino
acid chain (translation), posttranslational modification
in endoplasmic reticulum (ER) and Golgi apparatus
(Golgi) and secretion of the mature protein (Figure 1).
Metabolite demand for A1AT production was finally
simulated. These results indicate that one could
expect an increase in the production of glutamate and
glycine with increasing intracellular nucleotide
demand which was observedf o rA G E 1 . H N . A A T ;t h i s
is caused by differences in cellular composition of the
producer, partly originating from recombinant A1AT
production.
The differences that were found in the biomass com-
position between both cell lines were included in a
metabolic network model and intracellular metabolic
fluxes were calculated for both cell lines. Fluxes in cen-
tral energy metabolism (glyolysis, TCA cycle) were simi-
lar. Differences were observed in C1 and glutamate
metabolism including changes in activities of several
transaminases. The observed changes in metabolic flux
reflect the anabolic differences between producer and
parental cells.
Figure 1 Schematic presentation of the glycoprotein production process in mammalian cells.
Niklas et al. BMC Proceedings 2011, 5(Suppl 8):P85
http://www.biomedcentral.com/1753-6561/5/S8/P85
Page 2 of 3Conclusions
This improved understanding of the metabolism and
cellular changes during glycoprotein production sup-
ports the identification of targets for further improve-
ment of (i) cell line, e.g., by genetic modifications and
(ii) cultivation process, e.g., by improved feeding strate-
gies. The presented data indicate that nucleotide and
lipid metabolism might be interesting targets for further
engineering of the AGE1.HN
® cell line.
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